ArticleThe Journal of biological chemistry2012

CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant.

Yuanxi Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.